CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 331 enrolled
Drug / intervention
Drug-Coated Balloon (DCB) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01175850
NCT01175850N/ACompleted

Randomized Trial of IN.PACT Admiral(TM) Drug Coated Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease

Medtronic Endovascular·interventional·Posted Aug 5, 2010·Updated May 16, 2017

In Brief

A clinical study evaluating Drug-Coated Balloon (DCB) and PTA Balloon: Balloon Angioplasty for Peripheral Arterial Disease (PAD). Completed, enrolled 331 participants across 1 site.

Detailed Summary

The objective of this Study is to evaluate the safety and efficacy of the IN.PACT Admiral® drug coated PTA balloon, utilized for the dilatation of the narrowed sections of the artery, as compared to other standard (non drug coated) PTA balloons. The IN.PACT Admiral, besides the mechanical dilatation effect typical of all PTA balloons, releases a drug (paclitaxel) from the balloon surface into the vessel walls. This drug absorption is intended to limit the chances and the entity of artery re-narrowing over time.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedAug 5, 2010
Enrollment StartSep 1, 2010
Primary CompletionFeb 1, 2014
Study CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 15.9 years ago

Interventions

Drug-Coated Balloon (DCB)device

balloon dilatation and provisional stenting with IN.PACT DCB

PTA Balloon: Balloon Angioplastydevice

balloon dilatation and provisional stenting with standard non-coated PTA balloon